747 - Targeting enzalutamide-resistant prostate cancer using the novel androgen receptor inhibitor ODM-201

Autor: Borgmann, H., Ozistanbullu, D., Beraldi, E., Dalal, K., Fazli, L., Gleave, M.
Zdroj: In European Urology Supplements March 2017 16(3):e1290-e1290
Databáze: ScienceDirect